Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by cytochromeon May 10, 2016 2:27pm
112 Views
Post# 24858667

RE:Walt ... 904nm ... Anti-inflammatory ...

RE:Walt ... 904nm ... Anti-inflammatory ...Hey Dr Google Bencro,

Glad to see you've mastered the art of deception. Never said superpulsed was not effective.
Just that the action spectra (still not sure what theat is??? look it up herrrr Dr. Google) favours lower wavelengths (see Tiina Karu's research....knob). Not sure of teh importance of CCO action spectra......read a few papers. Already showed you evidence that depth of penetration is a contentious topic (refer to Anders et al paper). I was clear superpulsed is used in LLLT...hence the WALT guidelines to include it. Of course you have failed miserably in your feeble attempt to show the superiorty of superpulsed over shorter wavelengths. 

95% of all LLLT published research uses 660 nm and 780-840 nm. Hmmmmm........I wonder why??? Don't believe me? How about polishing up your Dr Google lenses and searching PubMed? Maybe even break out a different colour hi-liter for a change LOL.
The only clown around here is you pal.
Bullboard Posts